NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Necessity Retail REIT, Inc. ("Necessity Retail" or the "Company") (NASDAQ:RTL) who received shares of Global Net Lease, Inc. ("Global Net Lease") in connection with Global Net Lease’s acquisition of Necessity Retail on September […]
Cloud Database Market Poised for Explosive Growth, Projected to Hit USD 62.25 Billion by 2032 GlobeNewswire August 07, 2025 Burlingame, CA, Aug. 07, 2025 (GLOBE NEWSWIRE) — The Global Cloud Database Market is estimated to be valued at USD 22.43 Bn in 2025 and is expected to reach USD 62.25 Bn by 2032, exhibiting a
Poultry Antibiotic Market Poised for Growth, Expected to Hit USD 3.38 Billion by 2032 -Coherent Market Insights GlobeNewswire August 07, 2025 Burlingame, CA, Aug. 07, 2025 (GLOBE NEWSWIRE) — The Global Poultry Antibiotic Market is estimated to be valued at USD 2.25 Bn in 2025 and is expected to reach USD 3.38 Bn in 2032,
Kedrion is proud to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to investigational treatment for Congenital Aceruloplasminemia, a rare genetic disorder affecting iron metabolism. https://mma.prnewswire.com/media/2680007/Kedrion_Biopharma_Logo.jpg This designation marks a significant milestone in Kedrion's commitment to addressing the unmet medical needs of patients living with ultra-rare diseases and exemplifies
NEW YORK, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of BellRing Brands, Inc. ("BellRing" or the "Company") (NYSE:BRBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether BellRing and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ:EXEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Exelixis and certain of its officers and/or directors have
NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Albany International Corp. ("Albany" or the "Company") (NYSE:AIN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Albany and certain of its officers and/or
Conexiom, the leader in AI-powered order automation and performance optimization for manufacturers and distributors, today announced the appointment of Darren Bonnstetter as Chief Executive Officer. He succeeds John McNeill, who is retiring after guiding Conexiom through a period of rapid innovation and growth. https://mma.prnewswire.com/media/2746251/Darren_pic_Conexiom.jpg Bonnstetter brings more than two decades of experience helping companies harness
NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. ("Dyne" or the "Company") (NASDAQ:DYN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Dyne and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. ("Harrow" or the "Company") (NASDAQ:HROW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Harrow and certain of its officers and/or directors